The authors conducted a cohort study of nonsteroidal antiinflammatory drug (NSAID) use
and risk of symptomatic benign prostatic hyperplasia (BPH), using data from 4,735 men …

BACKGROUND Inflammation may play a role in pathogenesis of benign prostatic
hyperplasia (BPH). However, the role of non‐steroidal anti‐inflammatory drugs (NSAIDs) as …

Abstract In 1990–2002, the authors conducted a population-based cohort study of 2,447
Caucasian men in Olmsted County, Minnesota, to determine whether daily users of …

Study Type–Therapy (cohort) Level of Evidence 4 What's known on the subject? and What
does the study add? Accumulating evidence suggests that inflammation may contribute to …

Background Despite strong laboratory evidence that non-steroidal anti-inflammatory drugs
(NSAIDs) could prevent prostate cancer, epidemiological studies have so far reported …

The association between use of aspirin and other nonsteroidal anti‐inflammatory drugs
(NSAIDs) and the risk of prostate cancer remains controversial despite many observational …

Background: Use of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) has
consistently been associated with a reduced risk of colon cancer. Recent epidemiologic …

The authors conducted a nested case-control study of serum inflammatory markers and risk
of symptomatic benign prostatic hyperplasia (BPH), using data from the placebo arm of the …

Purpose Increasing evidence suggests that aspirin use may protect against prostate cancer.
In a nationwide case–control study, using Danish high-quality registry data, we evaluated …

Background: Prostate cancer is considered a major health problem in western countries.
Promising results from observational studies on cancer at other sites fuelled the publication …